Share on LinkedInShare on LinkedIn

ARTICLE · 04 FEBRUARY 2026

Regulation On Products Derived From Cannabis Published

CBC Law
CBC Law
Contributor
CBC Law

CBC Law

CBC Law is an independent, full-service law firm serving local and international clients. With...

View firm profile
Explore more from CBC Law

The Regulation on Products Derived from Cannabis, published on 31 January 2026, regulates the production, licensing, traceability, export, and sale of medicinal products, health products...

TurkeyCannabis & Hemp

The Regulation on Products Derived from Cannabis, published on 31 January 2026, regulates the production, licensing, traceability, export, and sale of medicinal products, health products, personal care products with no narcotic effect, and support products derived from cannabis. The licensing and supervision of cannabis-derived products are carried out by the Ministry of Health and the Turkish Medicines and Medical Devices Agency (TMMDA). The maximum THC content for these products is set at 0.3%. Sales are permitted exclusively through pharmacies; medicinal products and health products may not be sold without a prescription. In addition, an electronic tracking system is mandatory, and a cosmetic product notification is required for personal care products.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from